Medical management of thyroid cancer: a risk adapted approach

Authors

  • R. Michael Tuttle MD,

    Corresponding author
    1. Joan and Sanford I. Weill Medical College of Cornell University, New York, New York
    2. Memorial Sloan Kettering Cancer Center, New York, New York
    • Associate Professor of Medicine, Memorial Sloan Kettering Cancer Center, Zuckerman Research Building, Room 834, 1275 York Avenue, New York, NY 10021; Fax: 646-888-2700.
    Search for more papers by this author
  • Rebecca Leboeuf MD,

    1. Joan and Sanford I. Weill Medical College of Cornell University, New York, New York
    2. Memorial Sloan Kettering Cancer Center, New York, New York
    Search for more papers by this author
    • Assistant Professor.

    • Assistant Attending.

  • Ashok R. Shaha

    1. Memorial Sloan Kettering Cancer Center, New York, New York
    Search for more papers by this author
    • Professor of Surgery.


Abstract

Risk adapted treatment recommendations are dependent on accurate predictions of the risk of recurrence, risk of death, and likely sites of recurrence. When combined with response to therapy assessments and secondary risk stratification during follow-up, this risk adapted approach will allow the clinician to tailor the aggressiveness of therapy and follow up to the risk of recurrence and death in individual patients. J. Surg. Oncol. 2008;97:712–716. © 2008 Wiley-Liss, Inc.

Ancillary